128 related articles for article (PubMed ID: 315284)
1. The response to 1,25-dihydroxycholecalciferol and to dihydrotachysterol in adult-onset hypophosphataemic osteomalacia.
Ahmed KY; Varghese Z; Moorhead JF; Wills MR
Clin Chim Acta; 1979 Sep; 97(1):33-7. PubMed ID: 315284
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxycholecalciferol in hypophosphataemic osteomalacia presenting in adults.
Offermann G; Delling G; Haussler MR
Acta Endocrinol (Copenh); 1978 Jun; 88(2):408-16. PubMed ID: 580838
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
4. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
Brickman AS; Norman AW
Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
[No Abstract] [Full Text] [Related]
5. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
Malluche HH; Goldstein DA; Massry SG
Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
[No Abstract] [Full Text] [Related]
6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
7. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
[TBL] [Abstract][Full Text] [Related]
8. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
Prior JC; Cameron EC; Ballon HS; Lirenman DS; Moriarty MV; Price JD
Am J Med; 1979 Oct; 67(4):583-9. PubMed ID: 386792
[TBL] [Abstract][Full Text] [Related]
9. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
Phillips ME; Havard J; Otterud B
Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic hypophosphataemic osteomalacia (author's transl)].
Offermann G; von Herrath D; Delling G
Dtsch Med Wochenschr; 1976 Nov; 101(46):1684-9. PubMed ID: 186246
[TBL] [Abstract][Full Text] [Related]
11. Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.
Ahmed KY; Varghese Z; Wills MR; Meinhard E; Skinner RK; Baillod RA; Moorhead JF
Lancet; 1976 Aug; 2(7983):439-42. PubMed ID: 73742
[TBL] [Abstract][Full Text] [Related]
12. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
Stamp TC
Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome.
Cameron EC; Prior JC; Ballon HS
Contrib Nephrol; 1980; 18():162-71. PubMed ID: 6986229
[TBL] [Abstract][Full Text] [Related]
15. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
Fujita T; Nomura M; Okajima S; Furuya H
J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
[No Abstract] [Full Text] [Related]
18. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
Scriver CR; Reade T; Halal F; Costa T; Cole DE
Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
[TBL] [Abstract][Full Text] [Related]
19. Lack of response of 1,25-dihydroxycholecalciferol to exogenous parathyroid hormone in a patient with treated pseudohypoparathyroidism.
Braun JJ; Birkenhäger JC; Visser TJ; Juttmann JR
Clin Endocrinol (Oxf); 1981 Apr; 14(4):403-7. PubMed ID: 6266703
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
